ClavystBio is a life sciences investor established by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and entrepreneurs to launch and grow global companies from Asia. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology.
| Website | https://www.clavystbio.com/ |
| Employees | 22 (22 on RocketReach) |
| Founded | 2022 |
| Industry | Investment Management |
| Keywords | Life Sciences Investment, Commercialization, Life Science Venture Capital, Venture Building, Biotechnology Venture Capital, Breakthrough Ideas, Medical Innovation, Healthcare Investment, Therapeutics Investment, Healthtech, Health Impact, Global Health, Pharmaceutical Investment, Seed Funding, Series A Funding, Entrepreneurs, Founders, Startups |
| Competitors | Tempus Labs, Inc., Invitae, GRAIL, Millennium Health, Foundation Medicine, carisls, Ambry Genetics, Guardant Health, Myriad Genetics, Exact Sciences +53 more (view full list) |
Looking for a particular ClavystBio employee's phone or email?
ClavystBio Questions
Khoo Shih is the CEO of ClavystBio.
22 people are employed at ClavystBio.
Top ClavystBio Employees
-
25+
-
23
-
23
-
Jason Ng
Legal Lead at ClavystBio
Singapore11 -
Ning Mao
Senior Associate at ClavystBio
Singapore43 -
13
Related Companies
G2Crowd Trusted
300K+
Plugin Users
